Second case of PML seen with psoriasis drug Raptiva
This article was originally published in Scrip
Executive Summary
Genentechhas issued a "Dear Healthcare Provider Letter" regarding a second case of progressive multifocal leucoencephalopathy (PML) in a patient taking its psoriasis treatment Raptiva (efalizumab) which resulted in death, and said it was working with the US FDA to determine its next steps.